BioCentury
ARTICLE | Company News

Saliva Diagnostic Systems Inc., Kreatech Biotechnology other research news

April 15, 2013 7:00 AM UTC

SALV subsidiary SDS International Ltd. (London, U.K.) and Kreatech Diagnostics were awarded a grant by the European Union to aid in developing a rapid test for TB. The EU will provide ECU500,000 (U.S.$565,000) for research on the tests to be performed by a network of European research centers. ...